Status:
COMPLETED
The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
Lead Sponsor:
The Cleveland Clinic
Conditions:
Colonoscopy
Eligibility:
All Genders
5-21 years
Brief Summary
Bowel preparation solutions containing Polyethylene Glycol is a commonly used preparation of the colon for colonoscopy in children. However young children and adolescents often subject to the volume a...
Detailed Description
Inclusion Criteria: 1. Patients five years old or older that present to the pediatric GI clinic and are capable of taking oral liquids and have been scheduled for a colonoscopy. 2. Patients who are a...
Eligibility Criteria
Inclusion
- Patients five years old or older that present to the pediatric GI clinic and are capable of taking oral liquids and have been scheduled for a colonoscopy.
- Patients who are able to communicate their discomfort and preferences.
Exclusion
- Patients that are neurologically compromised
- Patients in need of emergent colonoscopy
- Patients with known metabolic, endocrine, renal or cardiac conditions.
- Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal obstruction or swallowing difficulties.
- Patients with known electrolyte abnormalities.
- Patients who are allergic to PEG-3350.
- Patients that are known to be pregnant.
- Patients with known fructose intolerance.
- Patient younger than five years old.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01164410
Start Date
August 1 2009
End Date
June 1 2010
Last Update
October 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Childrens Hospital
Cleveland, Ohio, United States, 44124